Global In-Vitro Fertilization Market valued at $1.25 billion (2021), is forecasted to witness a growth of 8% by 2026 - Decreasing Fertility Rate & Growing Cases of Male Infertility among Men

In-Vitro Fertilization (IVF) is an assisted reproductive technology (ART) that involves series of medical procedures that are used to help with fertility or prevent genetic problems and assist with the conception of a child.

Covid-19 Impact on the Global In-Vitro Fertilization Market

The outbreak of the Covid-19 virus had impacted the in-vitro fertilization market in terms of the number of treatments and fertility services as IVF clinics had to shut down to reduce the spread of the virus. The virus had also halted the IVF tourism in several cost-effective regions. However, the global in-vitro fertilization market is now in a recovery phase due to the consistent efforts of IVF clinics to meet the pent-up need that was caused by the cancelled treatments.

The Covid-19 pandemic has paved the way for digital adoption in the IVF sector to gain operational efficiency and telehealth adoption to survive and thrive in uncertain times. To overcome the health and medical challenges caused by the virus, IVF clinics have cross-trained their staff and replaced physical patient interactions with digital communication. To resume operations, IVF clinics are now stringently following Covid-safety protocols and in-person consultations are being replaced with online consultations. IVF clinics are further poised to embrace the growing trend of online consultations and video consultations which are likely to be the new norm in the in-vitro fertilization market.

Rising In-Vitro Fertilization (IVF) Tourism Boosts the In-Vitro Fertilization Market Growth

In recent years, there has been a growing trend towards IVF tourism. It is a type of medical tourism in which patients travel to other states or regions seeking fertility treatments in various forms. India, Spain, Czech Republic, Greece, Turkey, and Denmark have emerged as top IVF destinations. The primary reasons why people travel abroad for IVF treatments are as follows:
• Lower costs of treatments in other countries.
• Availability of well-equipped IVF clinics with high-class infrastructures and skilled professionals.
• The treatments are not legally available in the home country.
• Specific countries can provide the desired genealogy, among others.

"IVF tourism is a major factor driving the in-vitro fertilization market. The growing prominence of lesser-known destinations such as Grand Cayman Island and Barbados due to favourable regulations, low treatment costs, and availability of PGD is a pivotal contributing factor propelling it's growth." - Director, Leading IVF Equipment Manufacturer, United States

Growth Strategies Adopted by Leading Market Players to Establish Their Foothold in In-Vitro Fertilization Market

The established players operating in the global in-vitro fertilization market have adopted both organic and inorganic growth strategies such as new product launches, innovations, collaborations and partnerships to garner a higher market share.

For instance,
• In February 2022, CooperSurgical entered into an $875 million deal to purchase Cook Medical's reproductive health portfolio, which includes medical devices for fertility, obstetrics, gynecology, and in vitro fertilization.

Competitive Landscape Analysis: In-Vitro Fertilization Market

The global in-vitro fertilization market is marked by the presence of established and new market players such The Cooper Companies Inc., Vitrolife, Thermo Fisher Scientific, Esco Medical, IVFtech ApS, FUJIFILM Irvine Scientific, Kitazato Corporation, FERTIPRO NV, Gynotec B.V., among others.

Get Detailed Insights on In-Vitro Fertilization Market with a Sample Report @ https://meditechinsights.com/in-vitro-fertilization-ivf-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.